Skip to main content
OpenTrials
Completed

NCT Number: NCT02665208

A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients

The primary purpose of this study is to understand the feasibility of a text messaging intervention developed by the National Cancer Institute, known as Smokefreetxt, to improve smoking cessation among opiate and/or alcohol dependent participants discharged from an inpatient detoxification unit and enrolled in an office-based buprenorphine program patients (OBBP). Participants will be randomized to 1) treatment as usual (TAU) comprised of informational pamphlets and information for a 1800 quit line; and a prescription for a nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg) #10, for 28 days which is offered routinely to all inpatients at Bellevue at the time of discharge) versus the SmokeFreeTXT intervention plus prescriptions for NRT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Chemically-Induced Disorders Health Behavior Mental Disorders Narcotic-Related Disorders Opioid-Related Disorders Smoking Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University School of Medicine

New York, 10016, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • self-described every or some day smoker
  • diagnosed with opiate dependence and/or alcohol dependence (DSM-IV) per Physician medical records (MISYS)
  • Fluency in English and able to provide a written informed consent
  • Currently owning a mobile phone with a working phone number
  • Expected to reside in the New York City area for the next 12 months
  • Understands and able to respond to the intervention text message

Exclusion criteria

  • inability to read or understand English
  • currently using nicotine replacement therapies (patch, gum, e-cigarettes), pharmacotherapy for smoking cessation such as bupropion (zyban, wellbutrin), varenicline (Chantix).
  • suicidal or homicidal ideations
  • any ongoing psychotic disorder, life-threatening medical or psychiatric condition
  • leaves the inpatient detoxification unit prior to completing study enrollment
  • is pregnant, nursing or planning to conceive within the duration of the study period

Treatment and study plan

Treatment as usual (TAU)

Other

informational pamphlets and information from 1800 quit line + prescription for nicotine replacement therapy (NRT) based on on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg)

Nicotine Replacement Therapies

Drug

a prescription for a nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg)

Text Message Intervention (TMI)

Behavioral

Primary outcomes

  1. Difference in patient acceptability assessed via rates of participant adoption of TMI

    Time frame: 24 Weeks

  2. Feasibility measured by rates of retention in the TMI

    Time frame: 24 Weeks

  3. Clinical impact assessed using self-reported abstinence at week 1 via a text message inquiry from study

    Time frame: 24 Weeks

Secondary outcomes

  1. Change in pattern of mobile device, computer, and internet usage.

    Time frame: 24 Weeks

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Official study title

Mobile Phone Messaging to Support Smoking Cessation Among Office-based Buprenorphine and Inpatient Detoxification Patients: a Pilot Study

Important dates

Study start
2015
Primary completion
2015
Study completion
2017
First posted
Jan 27, 2016
Registry last updated
Dec 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.